| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.74B | 106.70B | 96.47B | 88.16B | 65.70B | 54.50B |
| Gross Profit | 51.26B | 49.82B | 23.32B | 41.19B | 17.18B | 11.89B |
| EBITDA | 21.14B | 21.02B | 21.26B | 19.64B | 15.67B | 11.61B |
| Net Income | 12.69B | 12.67B | 13.04B | 12.12B | 9.57B | 6.63B |
Balance Sheet | ||||||
| Total Assets | 94.03B | 96.44B | 84.89B | 81.98B | 60.91B | 50.73B |
| Cash, Cash Equivalents and Short-Term Investments | 13.14B | 25.25B | 26.84B | 27.98B | 20.66B | 17.47B |
| Total Debt | 5.76B | 5.78B | 6.59B | 4.54B | 4.77B | 4.80B |
| Total Liabilities | 34.24B | 35.46B | 31.41B | 37.45B | 19.15B | 15.90B |
| Stockholders Equity | 60.98B | 60.80B | 53.27B | 44.35B | 41.63B | 34.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.70B | 12.40B | 11.30B | 8.44B | 12.50B |
| Operating Cash Flow | 0.00 | 14.81B | 14.93B | 13.05B | 10.06B | 13.27B |
| Investing Cash Flow | 0.00 | -5.09B | -2.33B | -5.72B | -4.48B | -10.05B |
| Financing Cash Flow | 0.00 | -7.18B | -6.58B | -4.43B | -4.98B | -3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹582.12B | 49.66 | ― | 0.88% | 41.97% | 38.73% | |
73 Outperform | ₹551.14B | 30.78 | ― | 1.94% | 8.73% | 11.33% | |
70 Outperform | ₹266.72B | 38.46 | ― | 1.26% | 0.29% | 7.17% | |
69 Neutral | ₹333.67B | 42.81 | ― | 0.69% | 13.34% | 5.98% | |
66 Neutral | ₹335.12B | 49.96 | ― | 1.38% | -1.19% | -17.92% | |
62 Neutral | ₹488.54B | 38.20 | ― | 1.19% | 14.88% | -2.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
L&T Technology Services has announced the development of an AI-powered digital twin platform for respiratory diagnostics, in collaboration with NVIDIA. This platform, to be unveiled at the RSNA 2025, integrates with CT imaging and uses deep learning models to create a 3D digital twin of lung anatomy, enhancing diagnostic precision and aiding in surgical planning for conditions like lung cancer and COPD. The collaboration aims to transform healthcare by providing clinicians with real-time visualization and intelligent guidance, ultimately improving patient outcomes.
L&T Technology Services (LTTS) has been recertified at Caterpillar’s Supplier Excellence Recognition event for the second consecutive year, highlighting its consistent delivery, quality standards, and strategic relationship in the Mobility segment. This achievement underscores LTTS’s reliability and operational excellence in supporting Caterpillar’s global supply chain, furthering sustainability goals, and driving engineering innovation. The recognition reflects LTTS’s ability to meet strict criteria in quality assurance, timely delivery, and innovation, reinforcing its position as a strategic supplier to Caterpillar.
L&T Technology Services has announced an expanded partnership with Siemens Limited to drive AI-led transformation in process engineering and smart manufacturing. This collaboration aims to leverage Siemens’ digital technology portfolio to deliver simulation-driven automation and IIoT-enabled solutions, enhancing LTTS’ Sustainability segment. The partnership is expected to accelerate digital adoption, improve precision in system design, and foster smarter decision-making, positioning LTTS at the forefront of creating intelligent and environmentally responsible industrial ecosystems.
L&T Technology Services Limited announced the allotment of 6,775 equity shares to employees who exercised their stock options under the company’s Employee Stock Option Scheme, 2016. This move is part of the company’s ongoing efforts to incentivize and retain talent, ensuring that the newly allotted shares will hold the same rights as existing shares, thereby maintaining equity consistency and potentially enhancing employee engagement.